MedTrace Logo

Basal Insulin And Compensation Glycemic In Diabetic Patients In Basal Bolus Outpatient.

NCT03489031 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1036

Last updated 2018-04-05

No results posted yet for this study

Summary

Multicentric, observational, cross-sectional study in Italy. The aims are to evaluate the basal/total ratio of daily insulin dose (b/T) in diabetic outpatients type 1 (T1) and type 2 (T2) on basal-bolus regimen, by investigating whether there is a relationship with HbA1c and episodes of hypoglycemia.

Conditions

  • Diabetes Mellitus, Type 1
  • Diabetes Mellitus, Type 2

Sponsors & Collaborators

  • Associazione Medici Endocrinologi

    lead OTHER

Principal Investigators

  • Giorgio Borretta, MD · Associazione Medici Endocrinologi

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-11
Primary Completion
2016-09-30
Completion
2017-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03489031 on ClinicalTrials.gov